What medications does CSL Plasma make?
What medications does CSL Plasma make?
Drugs Associated with CSL Behring
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
| Alburx Generic name: albumin human Drug class: plasma expanders | ||
| Berinert Generic name: C1 esterase inhibitor (human) Drug class: hereditary angioedema agents | 2 reviews | 10 / 10 |
| Carimune NF Generic name: immune globulin intravenous Drug class: immune globulins |
What does CSL stand for?
CSL
| Acronym | Definition |
|---|---|
| CSL | Chinese Super League |
| CSL | Commonwealth Serum Laboratories (CSL Limited, Australian biopharmaceutical company) |
| CSL | Communication Services Ltd. (various locations) |
| CSL | Creosote Sweeping Log (fireplace cleaning product) |
What is CSL medication?
CSL Behring is a specialty biotherapeutics company built on more than a century of service to people with serious medical conditions around the world. Biotherapies differ from conventional chemical-based pharmaceuticals in that they derive from human blood plasma or are manufactured using recombinant technologies.
Who is the owner of CSL?
CSL Behring
| Industry | Biopharmaceutical, health care |
|---|---|
| Key people | Paul Perreault, CEO and Managing Director of CSL Limited |
| Number of employees | 27,000+ |
| Parent | CSL Limited |
| Website | www.cslbehring.com |
What does CSL Behring make?
CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.
What does CSL Behring do?
CSL Behring is a global biotechnology leader with the broadest range of quality medicines in the industry and substantial markets throughout the world. Our therapies are indicated for bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
When did CSL buy Behring?
2004
In 2004, during a period of plasma oversupply, the company expanded again with the purchase of the German medical company Aventis Behring. The company was the second Australian public company to have reached a share price of over $100 per share.
Is CSL making Covid vaccine?
CSL Reaffirms Commitment to Manufacture AstraZeneca COVID Vaccine into 2022. Melbourne, Australia: CSL is committed to the manufacture of approximately 50 million doses of the AstraZeneca COVID-19 vaccine, Vaxzevria.
Is CSL owned by the Australian government?
While it operated under public ownership, the objective of CSL was to provide health services to the Australian community, especially blood products, antivenoms and vaccines.
What companies does CSL Limited own?
They include: Aventis Behring, which is now known as global biotechnology leader CSL Behring; U.S. plasma collector Nabi, which helped to form the world’s premier plasma collection company in CSL Plasma; the Novartis influenza vaccine business, now integrated and known as Seqirus, the world’s second largest influenza …
Is CSL a good company?
CSL’s Earnings Per Share Are Growing. That makes EPS growth an attractive quality for any company. Over the last three years, CSL has grown EPS by 11% per year. That growth rate is fairly good, assuming the company can keep it up.
Will CSL produce Covid vaccine?